Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
US Army
Cerilliant
Argus Health
Johnson and Johnson
QuintilesIMS
Dow
Federal Trade Commission
Healthtrust
McKinsey

Generated: August 19, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Chlorpheniramine therapy
Abstract:An osmotic dosage form is disclosed for delivering chlorpheniramine.
Inventor(s): Stephens; Sally I. (Mountain View, CA), Hamel; Lawrence G. (Sunnyvale, CA), Barclay; Glen E. (Sunnyvale, CA), Wong; Patrick S. L. (Hayward, CA)
Assignee: Alza Corporation (Palo Alto, CA)
Application Number:07/176,561
Patent Claims: 1. A dosage for for delivering chlorpheniramine to a biological environment of use, the dosage form comprising:

(a) a wall comprising in at least a part a composition comprising a member selected from the group consisting of a cellulose acylate, a cellulose diacylate and a cellulose triacylate, which wall is permeable to the passage of an exterior fluid, substantially impermeable to the passage of chlorpheniramine, and surrounds and forms:

(b) a compartment;

(c) a composition in the compartment comprising a dosage unit amount of chlorpheniramine and mannitol, with the amount of mannitol and the amount of chlorpheniramine being selected to provide a mannitol concentration of from 1.5 to 6 times greater than the chlorpheniramine; and,

(d) at least one passageway in the wall connecting the compartment with the exterior of the dosage form for dispensing chlorpheniramine at a substantially even rate to the environment of use over time.

2. The dosage form for delivering chlorpheniramine according to claim 1, wherein chlorpheniramine is present as a pharmaceutically acceptable salt.

3. The dosage form for delivering chlorpheniramine according to claim 1, wherein the composition comprises chlorpheniramine present as a pharmaceutically acceptable salt and mannitol.

4. The dosage form for delivering chlorpheniramine according to claim 1, wherein chlorpheniramine is present as chlorpheniramine meleate.

5. The dosage form for delivering chlorpheniramine according to claim 1, wherein the cellulose triacylate is cellulose triacetate.

6. The dosage form for delivering chlorpheniramine according to claim 1, wherein the compartment comprises from 2 to 24 mg of chlorpheniramine.

7. The dosage form for delivering chlorpheniramine according to claim 1, wherein the dosage form comprises an outermost layer comprising chlorpheniramine.

8. The dosage form for delivering chlorpheniramine according to claim 1, wherein the dosage form comprises an outermost layer comprising from 1 to 15 mg of chlorpheniramine.

9. The dosage form for delivering chlorpheniramine according to claim 1, wherein environment of use is the gastrointestinal tract, and the dosage form is adapted for oral admittance into said environment of use.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Teva
US Department of Justice
US Army
Baxter
Argus Health
Harvard Business School
Cerilliant
UBS
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot